A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HP SEC filings page.
Helmerich & Payne, Inc. (HP) reported $4.0B in revenue over the twelve months to Jun 30, 2026, up 16.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue grew, but margin compression, heavier financing, and greater capital needs left 2025 barely profitable operationally and loss-making overall.
Despite a net loss of$164M , 2025 operating cash flow remained$543M , showing that accounting earnings were depressed more than near-term cash generation. Yet free cash flow was only$117M after$426M of capital spending, so positive cash conversion coexisted with substantial reinvestment.
From FY2023 to FY2025, revenue rose to
The balance sheet became materially more asset-heavy: total assets rose from
Financial Health Signals
Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Helmerich & Payne, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Helmerich & Payne, Inc. has an operating margin of 0.1%, meaning the company retains less than $1 of operating profit per $100 of revenue. This results in a moderate score of 42/100, indicating healthy but not exceptional operating efficiency. This is down from 16.6% the prior year.
Helmerich & Payne, Inc.'s revenue surged 35.9% year-over-year to $3.7B, reflecting rapid business expansion. This strong growth earns a score of 75/100.
Helmerich & Payne, Inc. has elevated debt relative to equity (D/E of 0.73), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 25/100, reflecting increased financial risk.
With a current ratio of 1.80, Helmerich & Payne, Inc. holds $1.80 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 66/100.
Helmerich & Payne, Inc. has a free cash flow margin of 3.1%, earning a moderate score of 56/100. The company generates positive cash flow after capital investments, but with room for improvement.
Helmerich & Payne, Inc. posts a -5.8% return on equity (ROE), meaning it loses $6 for every $100 of shareholders' equity. This results in a returns score of 37/100. This is down from 11.8% the prior year.
Helmerich & Payne, Inc. scores 1.84, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Helmerich & Payne, Inc. passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Helmerich & Payne, Inc. reported a net loss of $163.7M while generating $543.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Helmerich & Payne, Inc. earns $0.03 in operating income for every $1 of interest expense ($3.3M vs $107.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Helmerich & Payne, Inc. generated $1.0B in revenue in Q3 2026. This represents a decrease of 0.6% from the same quarter a year earlier. Against the prior quarter it is up 11.0%.
Helmerich & Payne, Inc.'s EBITDA was $369.2M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 620.7% from the same quarter a year earlier. Against the prior quarter it is up 156.7%.
Helmerich & Payne, Inc. reported $75.7M in net income in Q3 2026. This represents an increase of 146.5% from the same quarter a year earlier. Against the prior quarter it is up 229.1%.
Helmerich & Payne, Inc. earned $0.74 per diluted share (EPS) in Q3 2026. This represents an increase of 145.1% from the same quarter a year earlier. Against the prior quarter it is up 225.4%.
Cash & Balance Sheet
Helmerich & Payne, Inc. generated $83.9M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 241.1% from the same quarter a year earlier. Against the prior quarter it is up 419.2%.
Helmerich & Payne, Inc. held $204.4M in cash against $1.9B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Helmerich & Payne, Inc.'s gross margin was 33.8% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.7 percentage points.
Helmerich & Payne, Inc.'s operating margin was 18.2% in Q3 2026, reflecting core business profitability. This is up 30.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.1 percentage points.
Helmerich & Payne, Inc.'s net profit margin was 7.3% in Q3 2026, showing the share of revenue converted to profit. This is up 22.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.6 percentage points.
Helmerich & Payne, Inc.'s ROE was 2.8% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 8.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.1 percentage points.
Capital Allocation
Helmerich & Payne, Inc. invested $5.9M in research and development in Q3 2026. This represents a decrease of 24.0% from the same quarter a year earlier. Against the prior quarter it is down 15.8%.
Helmerich & Payne, Inc. invested $69.8M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 28.1% from the same quarter a year earlier. Against the prior quarter it is up 11.0%.
Not reported for Q3 2026.
HP Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B-0.6% | $932.4M-8.2% | $1.0B+50.2% | $1.0B+45.8% | $1.0B+49.2% | $1.0B+47.7% | $677.3M0.0% | $693.8M+5.2% |
| Cost of Revenue | $684.9M-2.7% | $661.2M-5.8% | $682.8M+66.2% | $694.6M+71.4% | $704.2M+69.7% | $701.7M+74.8% | $410.9M+1.9% | $405.2M+0.8% |
| Gross Profit | $349.9M+3.9% | $271.2M-13.7% | $334.2M+25.5% | $317.1M+9.9% | $336.7M+19.0% | $314.4M+9.7% | $266.4M-2.7% | $288.6M+12.1% |
| R&D Expenses | $5.9M-24.0% | $7.0M-25.5% | $6.6M-29.0% | $7.6M-14.8% | $7.8M-26.3% | $9.4M-27.0% | $9.4M+8.7% | $8.9M+20.4% |
| SG&A Expenses | $65.8M+0.5% | $71.1M-12.0% | $70.4M+11.6% | $77.6M+16.0% | $65.5M+8.8% | $80.8M+32.1% | $63.1M+11.5% | $66.9M+19.3% |
| Operating Income | $188.2M+246.7% | -$36.9M-187.6% | -$59.9M-165.9% | -$1.5M-101.3% | -$128.3M-213.1% | $42.2M-62.1% | $90.9M-26.4% | $109.4M+9.2% |
| EBITDA | $369.2M+620.7% | $143.8M-28.0% | $122.0M-35.8% | $187.4M-10.9% | $51.2M-75.8% | $199.8M-7.4% | $190.0M-12.6% | $210.3M+8.0% |
| Interest Expense | $24.4M-16.3% | $25.8M-8.9% | $25.6M+14.8% | $28.0M+73.5% | $29.2M+573.4% | $28.3M+565.1% | $22.3M+410.0% | $16.1M+269.4% |
| Income Tax | $72.4M+149.6% | $9.3M-77.6% | $11.2M-48.3% | -$6.3M-115.3% | $29.0M-14.0% | $41.5M+28.8% | $21.6M-28.0% | $40.9M+16.5% |
| Net Income | $75.7M+146.5% | -$58.6M-3643.5% | -$96.7M-276.6% | -$57.4M-176.0% | -$162.8M-283.5% | $1.7M-98.1% | $54.8M-42.5% | $75.5M-2.8% |
| EPS (Basic) | $0.74+145.1% | -$0.59-6000.0% | -$0.98-278.2% | -$0.58-177.3% | -$1.64-284.3% | $0.01-98.8% | $0.55-42.1% | $0.75-3.8% |
| EPS (Diluted) | $0.74+145.1% | -$0.59 | -$0.98-281.5% | -$0.58-176.3% | -$1.64-286.4% | $0.01 | $0.54-42.6% | $0.76-1.3% |
| Diluted Shares (Avg) | 100M+0.6% | 100M | 100M+0.4% | N/A | 99M+0.4% | 99M | 99M-0.5% | N/A |
HP Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.3B-8.4% | $6.3B-12.5% | $6.5B+11.0% | $6.7B+16.0% | $6.9B+53.0% | $7.2B+63.7% | $5.8B+31.6% | $5.8B+31.9% |
| Current Assets | $1.6B+5.4% | $1.5B-1.4% | $1.5B+19.4% | $1.5B+22.9% | $1.5B+53.6% | $1.5B+57.4% | $1.2B+23.9% | $1.2B+18.4% |
| Cash & Equivalents | $204.4M+23.1% | $177.2M+1.4% | $247.2M-36.8% | $196.8M-9.4% | $166.1M-18.4% | $174.8M-9.7% | $391.2M+82.7% | $217.3M-15.5% |
| Short-Term Investments | $27.0M+26.4% | $22.0M+5.4% | $21.8M-83.9% | $21.5M-92.7% | $21.3M-75.2% | $20.8M-75.0% | $135.3M+60.9% | $292.9M+212.9% |
| Inventory | $325.8M-1.3% | $330.5M+2.8% | $324.8M+155.2% | $324.3M+175.1% | $330.0M+186.2% | $321.6M+200.0% | $127.3M+25.5% | $117.9M+25.1% |
| Accounts Receivable | N/A | N/A | N/A | $752.8M+79.8% | N/A | N/A | N/A | $418.6M+3.8% |
| Long-Term Investments | $72.9M-28.9% | $85.6M-35.2% | $70.5M-30.6% | $68.2M-32.2% | $102.4M-64.9% | $132.0M-51.9% | $101.7M-61.4% | $100.6M-62.0% |
| Goodwill | $182.4M+9.5% | $183.8M-46.5% | $182.6M+299.9% | $182.9M+300.5% | $166.6M+264.8% | $343.8M+653.1% | $45.7M0.0% | $45.7M0.0% |
| Total Liabilities | $3.6B-9.5% | $3.7B-11.5% | $3.8B+30.9% | $3.9B+35.3% | $4.0B+145.4% | $4.2B+158.4% | $2.9B+72.7% | $2.9B+77.9% |
| Current Liabilities | $800.5M-1.1% | $863.3M-2.7% | $721.9M+65.7% | $814.8M+82.3% | $809.8M+77.3% | $887.6M+102.3% | $435.7M-7.1% | $446.9M+6.7% |
| Non-Current Liabilities | $2.8B-11.6% | $2.8B-13.9% | $3.0B+24.7% | $3.1B+26.6% | $3.2B+172.0% | $3.3B+179.2% | $2.4B+104.1% | $2.4B+103.0% |
| Long-Term Debt | $1.9B-15.1% | $1.9B-16.9% | $2.0B+13.7% | $2.1B+15.4% | $2.2B+300.5% | $2.2B+309.5% | $1.8B+226.7% | $1.8B+226.9% |
| Total Equity | $2.7B-6.8% | $2.6B-13.8% | $2.7B-8.3% | $2.8B-3.0% | $2.9B+0.3% | $3.1B+8.9% | $2.9B+6.8% | $2.9B+5.2% |
| Retained Earnings | $2.5B-8.8% | $2.4B-16.5% | $2.5B-14.3% | $2.6B-9.2% | $2.7B-4.6% | $2.9B+3.7% | $2.9B+6.2% | $2.9B+6.5% |
HP Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $153.7M+26.4% | $36.6M-34.7% | $182.4M+15.2% | $206.9M+22.6% | $121.6M-38.4% | $56.0M-61.0% | $158.4M-9.4% | $168.8M-21.4% |
| Depreciation & Amortization | $181.0M+0.8% | $180.7M+14.6% | $181.9M+83.6% | $188.9M+87.0% | $179.5M+83.5% | $157.7M+50.8% | $99.1M+5.4% | $101.0M+6.8% |
| Stock-Based Compensation | N/A | N/A | $9.3M+35.6% | N/A | N/A | N/A | $6.9M-10.7% | N/A |
| Capital Expenditures | $69.8M-28.1% | $62.9M-60.4% | $67.6M-36.5% | $64.1M-39.5% | $97.0M-27.8% | $158.7M+34.2% | $106.5M-21.9% | $106.0M-6.8% |
| Free Cash Flow | $83.9M+241.1% | -$26.3M+74.4% | $114.9M+121.4% | $142.8M+127.5% | $24.6M-61.0% | -$102.7M-504.0% | $51.9M+35.1% | $62.8M-37.8% |
| Investing Cash Flow | $68.1M+219.4% | -$54.0M+97.1% | -$58.3M-210.7% | -$52.8M+49.6% | -$57.0M+56.0% | -$1.9B-1576.9% | $52.7M+146.6% | -$104.8M+20.4% |
| Financing Cash Flow | -$174.5M-93.0% | -$58.3M-116.9% | -$69.8M-110.5% | -$154.0M-113.0% | -$90.5M-88.3% | $344.3M+797.3% | -$33.1M+66.4% | $1.2B+2519.6% |
| Dividends Paid | $25.4M+0.8% | $25.4M+0.5% | $25.2M+0.9% | $25.2M-40.1% | $25.2M-40.1% | $25.3M-39.9% | $25.0M-40.8% | $42.0M-14.0% |
| Share Buybacks | N/A | N/A | N/A | $0 | $0 | $0-100.0% | $0-100.0% | $0 |
HP Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.8%+1.5pp | 29.1%-1.9pp | 32.9%-6.5pp | 31.4%-10.2pp | 32.4%-8.2pp | 30.9%-10.7pp | 39.3%-1.1pp | 41.6%+2.5pp |
| Operating Margin | 18.2%+30.5pp | -4.0%-8.1pp | -5.9%-19.3pp | -0.1%-15.9pp | -12.3%-28.6pp | 4.2%-12.0pp | 13.4%-4.8pp | 15.8%+0.6pp |
| Net Margin | 7.3%+22.9pp | -6.3%-6.5pp | -9.5%-17.6pp | -5.7%-16.5pp | -15.6%-28.3pp | 0.2%-12.2pp | 8.1%-6.0pp | 10.9%-0.9pp |
| Return on Equity | 2.8%+8.5pp | -2.2%-2.3pp | -3.6%-5.4pp | -2.0%-4.6pp | -5.7%-8.8pp | 0.1%-3.0pp | 1.9%-1.6pp | 2.6%-0.2pp |
| Return on Assets | 1.2%+3.6pp | -0.9%-0.9pp | -1.5%-2.4pp | -0.9%-2.2pp | -2.4%-4.3pp | 0.0%-1.9pp | 0.9%-1.2pp | 1.3%-0.5pp |
| Current Ratio | 1.96+0.1x | 1.710.0x | 2.03-0.8x | 1.80-0.9x | 1.84-0.3x | 1.68-0.5x | 2.81+0.7x | 2.67+0.3x |
| Debt-to-Equity | 0.69-0.1x | 0.710.0x | 0.75+0.1x | 0.73+0.1x | 0.76+0.6x | 0.73+0.5x | 0.60+0.4x | 0.61+0.4x |
| Asset Turnover | 0.160.0x | 0.150.0x | 0.160.0x | 0.150.0x | 0.150.0x | 0.140.0x | 0.120.0x | 0.120.0x |
| FCF Margin | 8.1%+5.8pp | -2.8%+7.3pp | 11.3%+3.6pp | 14.1%+5.1pp | 2.4%-6.7pp | -10.1%-13.8pp | 7.7%+2.0pp | 9.0%-6.3pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Helmerich & Payne, Inc. HP | FY2025 | $3.7B | -$163.7M | -4.4% | $4.0B | 50/100 |
| Patterson-UTI Energy Inc PTEN | FY2025 | $4.8B | -$93.1M | -1.9% | $4.4B | 49/100 |
| Seadrill Limited SDRL | FY2025 | $1.4B | -$77.0M | -5.4% | $2.9B | 38/100 |
| Sable Offshore Corp. SOC | FY2025 | $0 | -$410.2M | N/A | $665.8M | — |
| Transocean LTD. RIG | FY2025 | $4.0B | -$2.9B | -73.5% | $6.2B | 47/100 |
| Noble Corporation plc NE | FY2025 | $3.3B | $216.7M | 6.6% | $6.8B | 52/100 |
Where Helmerich & Payne, Inc. Ranks
Frequently Asked Questions
What is Helmerich & Payne, Inc.'s annual revenue?
Helmerich & Payne, Inc. (HP) reported $3.7B in total revenue for fiscal year 2025. This represents a 35.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Helmerich & Payne, Inc.'s revenue growing?
Helmerich & Payne, Inc. (HP) revenue grew by 35.9% year-over-year, from $2.8B to $3.7B in fiscal year 2025.
Is Helmerich & Payne, Inc. profitable?
No, Helmerich & Payne, Inc. (HP) reported a net income of -$163.7M in fiscal year 2025, with a net profit margin of -4.4%.
What is Helmerich & Payne, Inc.'s EBITDA?
Helmerich & Payne, Inc. (HP) had EBITDA of $628.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Helmerich & Payne, Inc. have?
As of fiscal year 2025, Helmerich & Payne, Inc. (HP) had $196.8M in cash and equivalents against $2.1B in long-term debt.
What is Helmerich & Payne, Inc.'s gross margin?
Helmerich & Payne, Inc. (HP) had a gross margin of 33.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Helmerich & Payne, Inc.'s operating margin?
Helmerich & Payne, Inc. (HP) had an operating margin of 0.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Helmerich & Payne, Inc.'s net profit margin?
Helmerich & Payne, Inc. (HP) had a net profit margin of -4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Helmerich & Payne, Inc. pay dividends?
Yes, Helmerich & Payne, Inc. (HP) paid $0.25 per share in dividends during fiscal year 2025.
What is Helmerich & Payne, Inc.'s return on equity (ROE)?
Helmerich & Payne, Inc. (HP) has a return on equity of -5.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Helmerich & Payne, Inc.'s free cash flow?
Helmerich & Payne, Inc. (HP) generated $116.6M in free cash flow during fiscal year 2025. This represents a -38.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Helmerich & Payne, Inc.'s operating cash flow?
Helmerich & Payne, Inc. (HP) generated $543.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Helmerich & Payne, Inc.'s total assets?
Helmerich & Payne, Inc. (HP) had $6.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Helmerich & Payne, Inc.'s capital expenditures?
Helmerich & Payne, Inc. (HP) invested $426.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Helmerich & Payne, Inc. spend on research and development?
Helmerich & Payne, Inc. (HP) invested $34.1M in research and development during fiscal year 2025.
What is Helmerich & Payne, Inc.'s current ratio?
Helmerich & Payne, Inc. (HP) had a current ratio of 1.80 as of fiscal year 2025, which is generally considered healthy.
What is Helmerich & Payne, Inc.'s debt-to-equity ratio?
Helmerich & Payne, Inc. (HP) had a debt-to-equity ratio of 0.73 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Helmerich & Payne, Inc.'s return on assets (ROA)?
Helmerich & Payne, Inc. (HP) had a return on assets of -2.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Helmerich & Payne, Inc.'s P/E ratio?
Helmerich & Payne, Inc. (HP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $4.0B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Helmerich & Payne, Inc.'s price-to-sales ratio?
Helmerich & Payne, Inc. (HP) trades at 1.0x sales, its market capitalization divided by revenue of $4.0B revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.0B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Helmerich & Payne, Inc.'s Altman Z-Score?
Helmerich & Payne, Inc. (HP) has an Altman Z-Score of 1.84, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Helmerich & Payne, Inc.'s Piotroski F-Score?
Helmerich & Payne, Inc. (HP) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Helmerich & Payne, Inc.'s earnings high quality?
Helmerich & Payne, Inc. (HP) reported a net loss of $163.7M while generating $543.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Helmerich & Payne, Inc. cover its interest payments?
Helmerich & Payne, Inc. (HP) has an interest coverage ratio of 0.03x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Helmerich & Payne, Inc.?
Helmerich & Payne, Inc. (HP) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.